GSK1904529A selectively inhibits IGF-IR and IR with IC50s of 27 and 25 nmol/L, respectively. GSK1904529A shows poor activity (IC50>1 µM) in 45 other serine/threonine and tyrosine kinases. GSK1904529A exhibits anti-tumor activity.
Molecular Weight:
851.96
Purity:
99.14%
CAS Number:
[1089283-49-7]
Formula:
C44H47F2N9O5S
Target:
IGF-1R
* VAT and and shipping costs not included. Errors and price changes excepted
